<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Peripheral venous disease &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/peripheral-venous-disease/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Fri, 05 Jun 2026 10:55:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Peripheral venous disease &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency</title>
		<link>https://clinicaltrials.eu/trial/study-to-evaluate-the-efficacy-and-safety-of-personalized-tissue-engineered-veins-in-patients-with-severe-chronic-venous-insufficiency/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 30 Apr 2026 13:08:54 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-to-evaluate-the-efficacy-and-safety-of-personalized-tissue-engineered-veins-in-patients-with-severe-chronic-venous-insufficiency/</guid>

					<description><![CDATA[This study focuses on individuals living with Chronic Venous Insufficiency, a condition where the veins have trouble sending blood from the limbs back to the heart, often leading to swelling or skin issues. The research aims to evaluate the efficacy and safety of a Personalized Tissue Engineered Vein, referred to as P-TEV. This treatment involves [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This study focuses on individuals living with <b>Chronic Venous Insufficiency</b>, a condition where the veins have trouble sending blood from the limbs back to the heart, often leading to swelling or skin issues. The research aims to evaluate the efficacy and safety of a <b>Personalized Tissue Engineered Vein</b>, referred to as <b>P-TEV</b>. This treatment involves the <b>implantation</b> of a special graft made from <b>decellularised allogeneic vein tissue</b>, which is biological material from a donor that has had its cells removed to prevent rejection, combined with a functional valve and the patient&#8217;s own blood.</p>
<p>Participants in the study will receive either the <b>P-TEV</b> graft or a control treatment. Following the procedure, the progress of the condition and the healing of any <b>ulcers</b>, which are open sores on the skin, will be monitored over a period of time. The study will observe how well the new vein valves work and how much the physical symptoms and signs of the disease improve through regular check-ups using <b>ultrasound</b> imaging to look at blood flow.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
